In the past, natural substances served as the sources of all medicinal agents, and most of these remedies were obtained from higher plants. Currently, about 65-75% of the population of the world depends predominantly on plants and plant extracts for medicinal purposes [1] . From a recent survey of introduced drugs [2], 63% of the 847 small-molecule new chemical entities introduced as drugs worldwide during 1981-2006 can be traced to or were inspired by natural products. These include natural products themselves (5%), natural product derivatives (27%), synthetic compounds with natural-product-derived pharmacophores (6%), and synthetic compounds designed on the basis of knowledge gained from a natural product (i.e., natural product mimics, 25%).
Many of the latest additions to the cancer chemotherapy arsenal are plant derivatives [3] . The alkaloids vincristine and vinblastine, derived from the rosy periwinkle (Catharanthus roseus), have been used effectively since the early 1960's against leukemia [4] ; and etoposide, a semi-synthetic antineoplastic agent based on podophyllotoxin, a constituent of the mayapple, Podophyllum peltatum, has been useful against refractory testicular carcinomas, small cell lung carcinomas, nonlymphocytic leukemias, and non-Hodgkin's lymphomas [5] . Taxol ® , a diterpenoid derived from the Pacific yew tree (Taxus brevifolia), has been approved for treatment of ovarian cancer and breast cancer [6] .
Plant-derived products have been exceptional sources of useful drugs for hundreds of years. Tropical cloudforests provide a rich variety of unexplored plant species [5] . Like most tropical mountain ecosystems, the Monteverde region of the central Cordillera de Tilarán in northwestern Costa Rica is diverse both physiographically and climatically [7, 8] , resulting in extraordinary biodiversity. Monteverde, therefore, is one of the most floristically diverse regions in the world. The slopes of the Cordillera above 1200 m elevation contain ~1700 plant species, comparable to the La Selva Biological Station in the Caribbean lowlands of Costa Rica, or in the floodplains and upland terraces along the Rio Manú in the Amazonian lowlands of Peru, while the area above 700 m in the Cordillera de Tilarán contains ~3000 plant species. The pharmacological wealth of the tropics, as yet still largely unexplored [10] , is a result of both the species richness of the tropical flora, and the diversity of pathogens, parasites, and herbivores against which the plants must defend themselves. The diversity of consumers has inevitably selected for a diversity of defensive mechanisms, many of them chemical (see, e.g., [11] ). Many of these chemical defenses, because of their metabolic precision, can be used to solve human medical needs. We have been collecting plant material from the montane cloudforest at Monteverde, Costa Rica for 20 years, and this review presents a brief overview of some results from our efforts.
Bioactivity Screening:
We had concentrated our bioactivity screening efforts predominantly on antibacterial activity against a panel of Gram-positive (Bacillus cereus, Staphylococcus aureus, Streptococcus pneumoniae) and Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli), potential opportunistic pathogenic fungi (Candida albicans, Aspergillus niger), and cytotoxic activity against several human tumor cell lines (Hep-G2, SK-Mel-28, A-431, MDA-MB-231, MCF-7, Hs 578T, 5637, PC3) [12] . More recently, we have investigated inhibition of cysteine proteases as targets for phytochemically derived antitrypanosomal agents [13] . Selected biologically active crude plant extracts were subjected to activity-directed chromatographic separation and bioactive components identified using spectroscopic, chiefly NMR, methods.
Antineoplastic
Agents: Numerous plant-derived triterpenoids have shown cytotoxic activity [14] . Lupeol was found to be the cytotoxic principle in the ethanol leaf extract of Dendropanax querceti (Araliaceae) [15] , with IC 50 values of 77 and 101 μM on Hep-G2 (human hepatoma) and A-431 (human epidermoid carcinoma) cells, respectively.
The chloroform leaf extract of Alchornea latifolia (Euphorbiaceae) yielded cytotoxic seco-3,4-friedelin and seco-3,4-taraxerone [16] . These Aring-opened triterpenoids had IC 50 values of 35.5 and 11.7 μM, respectively, on Hep-G2, and 29.7 and 38.2 μM, respectively, on A-431 cells. All three of these cytotoxic triterpenoids inhibited topoisomerase II with MIC values of 50 μM, 7 μM, and 7 μM, respectively, for lupeol, seco-3,4-friedelin, and seco-3,4-taraxerone, comparable to that found for the positive control, etoposide (25 μM) [16] . Because the triterpenoids cannot intercalate DNA, they are likely catalytic inhibitors of topoisomerase II rather than topoisomerase II poisons [17] . In order to probe the potential binding sites of these triterpenoid inhibitors of topoisomerase II, molecular docking techniques were carried out and revealed the triterpenoids to preferentially bind to the DNA binding site of the enzyme (Figure 1 ) [18] . The cytotoxic quinone-methide triterpenoid, tingenone, was isolated from the chloroform bark extract of an as-yetundescribed Salacia (Hippocrateaceae) liana species [19] . In addition to tingenone, another quinone-methide triterpenoid, netzahualcoyonol, was isolated from the crude chloroform extract of the treelet, Salacia petenensis [20] . These quinone-methide triterpenoids exhibited potent in-vitro cytotoxic activity against Hep-G2 (IC 50 = 1.91 and 1.95 μM, respectively) and MDA-MB-231 (IC 50 = 1.49 and 1.23 μM, respectively) cell lines. The planar A and B rings of these compounds suggests that they can participate in a quasi-intercalative interaction with DNA allowing favorable frontier molecular orbital overlap between the HOMO of either the C-G or A-T base pairs and the LUMO of the triterpenoid [20] . This quasiintercalation, then, would orient the electrophilic C(6) of the triterpenoid into direct contact with a nucleophilic amino group of the purine base, leading to alkylation. Molecular docking studies ( Figure 2 ) are consistent with this mechanistic scenario.
The Araliaceae has been found to be a rich source of biologically active polyacetylenes [21] and members of the family from Monteverde have shown notable cytotoxic activity [22] . Dehydrofalcarindiol was isolated from the ethanol leaf extract of Dendropanax arboreus [23] . This diacetylene showed cytotoxic activities on Hep-G2 and A-431 cells (IC 50 = 35.8 and 115 μM, respectively). Cytotoxicity determinations of a series of synthetic diacetylenes has suggested that hydrophobicitylipophilicity is an important structural feature in the bioactivity of diacetylenes [24] and that the cytotoxic activity may be due to biomembrane permeability and influx of the compounds into the cells [25].
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Dehydrofalcarindiol
Quinoline alkaloids are abundant in the Rutaceae and a number of these compounds are planar aromatic heterocycles that have shown cytotoxic activity [26] . Some cytotoxic quinoline alkaloids have been found to inhibit either topoisomerase I or topoisomerase II by way of DNA intercalation [26] . HPLC-NMR / HPLC-MS analysis of the dichloromethane bark extract of Stauranthus perforatus has revealed several quinoline alkaloids and furanocoumarins [27] . The quinoline alkaloids skimmianine and veprisine were cytotoxic on Hep-G2 (IC 50 = 38.7 and 146 μM, respectively) and MDA-MB-231 cells (IC 50 = 130 and 203 μM, respectively), while the furanocoumarin heraclenin had IC 50 values of 60.1 and 184 μM on those two cell lines, respectively [28] . Molecular docking studies have shown that intercalation of the quinoline alkaloids skimmianine and stauranthine with DNA are such that there are favorable electrostatic interactions as well as frontier molecular orbital interactions with the C-G base pair [29] .
Heraclenin
The acetone bark extract of Lonchocarpus haberi (Fabaceae) was subjected to HPLC-NMR analysis revealing a number of prenylated flavonoids. Bioactivitydirected isolation led to four novel cytotoxic flavonoids, LOHA6, LOHA7, LOHA8, and LOHA9 [30] . Numerous flavonoids have shown antiproliferative activity attributable to interactions with several enzyme systems, including aromatase, fatty acid synthase, cyclooxygenase, xanthine oxidase, lipoxygenase, ornithine decarboxylase, protein tyrosine kinase, protein kinase C, phosphoinositide 3-kinase, topoisomerase I and II [31] . Molecular docking analyses have shown that prenylated flavonoids generally have stronger binding energies than their non-prenylated analogs to these key enzyme systems [32] . A novel fatty alcohol glycoside, 1-O-[2",3",4"-tri-Oacetyl-α-L-rhamnopyranosyl-(12)-β-D-glucopyranosyl]hexadecanol (cupanioside) was isolated from the crude dichloromethane bark extract of Cupania glabra (Sapindaceae) [33] . [49] . Activity-directed chromatographic separation of the crude bark extract of Salacia sp. "liana" led to four moderately active friedelane triterpenoids, 25,28-dihydroxyfriedelin (IC 50 = 154 μg/mL), canophyllol (IC 50 = 87.4 μg/mL), tingenone (IC 50 = 79.8 μg/mL), and the novel 29-hydroxyfriedelan-3-on-29-al (IC 50 = 71.1 μg/mL) [50] . Molecular docking studies have shown that these triterpenoid inhibitors bind to the hydrophobic "recognition site" of cruzain rather than the "active site" [51] . Rhodesain inhibitory studies have shown the acetone bark extract of Verbesina turbacensis to be active against that cysteine protease.
Activity-directed chromatographic separation led to isolation of three bornyl cinnamates as the active materials: bornyl coumarate (IC 50 = 92.2 μM), bornyl caffeate (IC 50 = 14.9 μM), and bornyl ferulate (IC 50 = 32.2 μM) [52] . In order to probe potential selectivity for the parasite enzyme, inhibitory screening of the compounds against human cathepsin L was also carried out. Bornyl coumarate, bornyl caffeate, and bornyl ferulate had IC 50 values of 132.2, 6.04, and 94.9 μM, respectively, against the human enzyme. Molecular docking studies showed that the bornyl esters bind to rhodesain at the active site (hydrogen bonding to Cys 25), and that the compounds dock more strongly to rhodesain than they do to human cathepsin L [52] .
Drugs from the Cloudforest
Natural Product Communications Vol. 6 (10) 2011 1553 Biologically Active Essential Oils: Numerous essential oils have been collected and evaluated for biological activity over the past few years (Table 1 ). Essential oils are complex mixtures, so correlation of activities with abundant individual components is difficult. Nevertheless, biological activities have been determined for a number of individual essential oil components (Table 2) . Additionally, there may be synergistic or antagonistic effects between chemical components. To examine potential synergism/antagonism, cytotoxicity [54] and cruzain inhibition [59] studies have been carried out between binary mixtures of selected essential oil components. Thus, for example, the cytotoxicity of βcaryophyllene was enhanced by the addition of either citronellal or hexanal, but the cytotoxicity of α-humulene was attenuated by α-pinene or β-pinene [54] . Similarly, neither 1,8-cineole nor caryophyllene oxide showed cruzain inhibitory activity (IC 50 > 500 μg/mL), but a 1:1 mixture of these compounds inhibited cruzain with and IC 50 of 98.5 μg/mL [59] . Conversely, β-caryophyllene and α-humulene both inhibited cruzain (IC 50 = 32.5 and 28.2 μg/mL, respectively), but a 1:1 mixture of the two sesquiterpenes was much less active (IC 50 = 296 μg/mL) [59] .
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